Patent details
LUC00117 Product Name: Paclitaxel micellaire
Basic Information
- Publication number:
- LUC00117
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP088615265
- Legal Status:
- Inactive
- Application number:
- LUC00117
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1292
- Marketing Authorization Type:
- Marketing Authorization Date:
- 22/11/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 03/05/2019
- First Marketing Authorization date:
- 22/11/2018
- Grant date:
- 22/05/2024
- Activation date:
- Publication date:
- 07/05/2019
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 22/11/2033
- SPC Extension Expiration:
- 22/11/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 11/11/2019
- Name:
- Oasmia Pharmaceutical AB
- Address:
- Vallongatan 1, 752 28, Uppsala, Sweden (SE)
History of Owners
- From:
- 03/05/2019
- To:
- 11/11/2019
- Name:
- Ardenia Investments Ltd.
- Address:
- First Floor 45 Welbeck Street, London, Greater London W1G 8DZ, United Kingdom (GB)
Agent
- Name:
- PLASSERAUD IP
- From:
- 03/05/2019
- Address:
- Rue de la Chaussée d'Antin 66, 75440, PARIS CEDEX 09, France (FR)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2019/07
- Publication date:
- 11/06/2019
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2019/13
- Publication date:
- 20/12/2019
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/07
- Publication date:
- 03/06/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20190000411A
- Date Registered:
- 11/11/2019
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Oasmia Pharmaceutical AB
- Address:
- Vallongatan 1, 752 28, Uppsala, Sweden (SE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 01/01/2029
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 28/11/2019 | Incoming Correspondence (Post) | 1 |
| 03/05/2019 | General Document | 35 |
| 11/11/2019 | Request For Change | 4 |
| 03/05/2019 | General Document | 3 |
| 03/05/2019 | General Document | 1 |
| 20/07/2020 | Outgoing Correspondence | 1 |
| 03/05/2019 | General Document | 16 |
| 07/05/2019 | Outgoing Correspondence | 1 |
| 19/11/2019 | Outgoing Correspondence | 1 |
| 03/05/2019 | Incoming Correspondence (Post) | 1 |
| 03/05/2019 | General Document | 121 |
| 03/05/2019 | Application Form | 3 |
| 20/07/2020 | Incoming Correspondence (Post) | 1 |
| 28/11/2019 | Outgoing Correspondence | 1 |
| 23/05/2024 | Outgoing Correspondence | 1 |
| 07/05/2019 | Publication | 1 |
| 22/05/2024 | Publication | 1 |
| 22/05/2024 | Certificate | 1 |